Authors: Dr Amanda Oakley, Dermatologist, Hamilton, New Zealand, 1997. Updated: Dr Claire Ronaldson, Medical Registrar, Latrobe Regional Hospital, Traralgon, Australia; A/Prof Rosemary Nixon AM, Dermatologist, Skin Health Institute, Melbourne, Australia. Copy edited by Gus Mitchell. August 2021
A house dust mite is an eight-legged arachnid with a three-month life cycle of egg, larva, protonymph, tritonymph, and adult stages. The adult mite is transparent and 0.25-0.33 mm in length. The female lays 50–80 eggs during her lifetime. Each immature mite stage sheds a hard exoskeleton of chitin which is an aeroallergen, although the main allergens derive from the membrane encasing faecal pellets. The house dust mite feeds on skin scales, so increased numbers are found in association with humans with dermatoses that cause increased skin shedding.
The most common house dust mite species in temperate zones are Dermatophagoides pteronyssinus (Der p), Dermatophagoides farina (Der f) and Euroglyphus maynei (Eur m). Blomia tropicalis (Blo t) is also found in tropical climates. House dust mites are not found in the Arctic or Antarctic due to the cold temperatures, or at high altitudes where there is low humidity - the mite requires a humidity level above 75%. House dust mites avoid light so appear on exposed surfaces only at night. The highest mite numbers are found in carpeted bedrooms and living rooms, in couches and beds, especially sheepskin bedding and clothing.
Who is affected by house dust mites?
House dust mites produce aeroallergens that can cause hypersensitivity particularly in atopic individuals — those with atopic dermatitis, allergic rhinitis, and allergic asthma.
House dust mites produce the most relevant airborne allergens for atopic dermatitis.
Particles containing mite allergens are undetectable in the air of undisturbed rooms, however will become airborne after disturbing contaminated surfaces such as making a bed or vacuuming carpet. Contact can also be more direct such as via pillows, soft toys, or clothing.
What causes house dust mite hypersensitivity?
House dust mite allergens may be inhaled, ingested, or contacted directly to the skin or eye.
There are many potential allergens related to house dust mites, the most sensitising of which are Der p1/Der f1 (cysteine proteases) and Der p2/Der f2 (lipid-binding auto-adjuvants). Der p11 (paramyosin homologue) is a major allergen in atopic dermatitis. Polysensitisation is common in atopic dermatitis.
Activate PAR-2 (protease-activated-receptor-2) in epidermalkeratinocytes and dermalnerves leading to non-histamine-mediated itch and delayed skin barrier healing
Promote cytokine-mediated inflammation
Disrupt the skin barrier function allowing interaction with local immune cells to initiate types I (immediate) and IV (delayed) hypersensitivity reactions. [see Allergies explained]
What are the clinical features of house dust mite?
House dust mite aeroallergens may cause exacerbation of atopic dermatitis on exposed sites such as the face and arms. There may be particular aggravation in the morning on skin that directly contacts bedsheets overnight. There may be a seasonal association with flares in Spring and Summer months.
House dust mite hypersensitivity also exacerbates allergic rhinitis, allergic conjunctivitis, and allergic asthma.
What are the complications of house dust mite hypersensitivity?
Secondary bacterialinfection of the skin following scratching
Atopic dermatitis resistant to treatment
Cross reaction with chitin in crustaceans and cockroaches (Der p10)
Impact on quality of life for the patient and their family
How is house dust mite hypersensitivity diagnosed?
House dust mite hypersensitivity should be considered clinically in atopic dermatitis refractory to treatment.
Colonisation with Staphylococcus aureus, Candida spp, or dermatophytes
Other airborne hypersensitivity reactions
What is the treatment for house dust mite hypersensitivity?
House dust mite eradication measures
Allergen-impermeable mattress and pillow covers
Carpet removal or frequent vacuuming
Washing clothes and bedlinen in hot water (>60C)
Dehumidification
Immunotherapy
Sublingual, subcutaneous, oral, and dermal routes
Allergen specific or crude house dust mite extracts
The effectiveness of eradication and desensitisation interventions remains uncertain and should only be considered in patients with atopic dermatitis and proven house dust mite hypersensitivity.
What is the outcome for house dust mite hypersensitivity?
Guidelines for the management of house dust mite hypersensitivity in atopic dermatitis remain unclear and inconsistent due to low-quality clinical trials.
Bibliography
Bumbacea RS, Corcea SL, Ali S, Dinica LC, Fanfaret IS, Boda D. Mite allergy and atopic dermatitis: is there a clear link?. Exp Ther Med. 2020;20(4):3554-60. doi:10.3892/etm.2020.9120. PubMed Central
Hostetler SG, Kaffenberger B, Hostetler T, Zirwas MJ. The role of airborne proteins in atopic dermatitis. J Clin Aesthet Dermatol. 2010;3(1):22–31. PubMed Central
Li L, Qian J, Zhou Y, Cui Y. Domestic mite-induced allergy: causes, diagnosis, and future prospects. Int J Immunopathol Pharmacol. 2018;32:2058738418804095. doi:10.1177/2058738418804095. Journal
Miller JD. The role of dust mites in allergy. Clin Rev Allergy Immunol. 2019;57(3):312–29. doi:10.1007/s12016-018-8693-0. PubMed
Nankervis H, Pynn EV, Boyle RJ, et al. House dust mite reduction and avoidance measures for treating eczema. Cochrane Database Syst Rev. 2015;1:CD008426. doi:10.1002/14651858.CD008426.pub2. Journal
Tam H, Calderon MA, Manikam L, et al. Specific allergen immunotherapy for the treatment of atopic eczema. Cochrane Database Syst Rev. 2016;2:CD008774. doi:10.1002/14651858.CD008774.pub2. Journal
Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018;32(6):850–78. doi:10.1111/jdv.14888. Journal
Yu N, Luo H, Liang D, Lu N. Sublingual immunotherapy in mite-sensitized patients with atopic dermatitis: a randomized controlled study. Postepy Dermatol Alergol. 2021;38(2):69–74. doi:10.5114/ada.2021.104281. PubMed Central